GuidelineAtencion primaria2026
[Integrated care for long-responder women with metastatic breast cancer: Expert opinion for long term management in spain].
Guideline in Atencion primaria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastatic breast cancer (mBC) has become a chronic disease for a growing number of women thanks to therapeutic advances, generating a new population of patients with prolonged response. This article, written by experts in oncology and primary care (PC) in Spain, offers practical recommendations for the comprehensive management of these patients. It addresses strategies to improve therapeutic compliance, the detection and management of toxicities, the early identification of signs of progression, and the management of comorbidities and drug interactions. In addition, it emphasizes the importance of psychosocial support, the promotion of healthy habits, and coordination between oncology and PC to optimize quality of life and continuity of care. The effective integration of PC in the follow-up of patients with mBC and prolonged response is key to maintaining therapeutic benefits and the overall well-being of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.